Clinical trial
Efficacy and Safety of M100907 on Sleep Maintenance Insomnia With a Sub-study in…
NCT00495885 · Sanofi, Industry · Completed
Key facts
| NCT number | NCT00495885 |
|---|---|
| Title | Efficacy and Safety of M100907 on Sleep Maintenance Insomnia With a Sub-study in Stable Type II Diabetes Mellitus |
| Official title | Efficacy and Safety of 2 mg/Day of M100907 on Sleep Maintenance Insomnia With a Sub-study of the Effect of M100907 on Stable Type II Diabetes Mellitus: a 12-week, Multi-center, Randomized, Double-blind, Placebo-controlled Study |
| Acronym | SAMS12 |
| Lead sponsor | Sanofi, Industry |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Sleep Initiation and Maintenance Disorders |
| Intervention type | Drug |
| Interventions | volinanserin (M100907), Placebo |
| Enrollment | 848 |
| Start date | Jun 1, 2007 |
| Primary completion | Oct 1, 2008 |
| Completion | Oct 1, 2008 |
| First posted | Jul 3, 2007 |
| Last update posted | May 26, 2016 |
| Countries | Brazil, Canada, Colombia, Czechia, Finland, France, Greece, Italy, Malaysia, Netherlands, Russia, South Africa and 4 more |
At a glance
- 10–99 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: